Stoke Therapeutics, Inc. STOK Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s income tax?
- Stoke Therapeutics, Inc. (STOK) reported income tax of -$0 in Q1 2026.
- How has Stoke Therapeutics, Inc.'s income tax changed year-over-year?
- Stoke Therapeutics, Inc.'s income tax decreased by 100.0% year-over-year, from $1.28M to -$0.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.